Epirubicin Hydrochloride Liposome Injection(Shandong New Time Pharma)
盐酸表柔比星脂质体注射液 (山东新时代药业)
Report date: 2025/08/25 14:04:35
Base Information
Drug NameEpirubicin Hydrochloride Liposome Injection(Shandong New Time Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong New Time Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShandong New Time Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A